HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Appears To Be Prepping For Cosmetics Regulatory Changes, Ingredient Review

This article was originally published in The Rose Sheet

Executive Summary

Proposed regulatory reform legislation in the Senate would require FDA to review the safety of cosmetics ingredients, taking into account evaluations conducted by accredited third parties. In August, FDA requested quotes from the contractor community for developing a cosmetic hazard and risk assessment protocol and optional certification program “to show compliance with the protocol.”

Advertisement

Related Content

2018 In Review: US Midterm Mania Stifles Cosmetics Regulatory Reform Momentum
Cosmetics Recalls For August-October Period Have One Familiar Thing In Common: All Were Voluntary
Keystone Labs Court-Ordered To Halt OTC Drug Manufacturing; Cosmetics Not Affected, It Says
FDA: Anonymity Assured In Pending Cosmetic Manufacturing Practices Survey
‘Something’s Going To Happen’: Former FDAer John Bailey On Cosmetics Reform Legislation
CIR Objectivity In Safety Substantiation Questioned By Women's Voices for Earth
Senate Health Committee Releases Cosmetics Reform Discussion Draft
FDA: Ingredient Safety Decisions Under PCPSA Could Differ From CIR
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA

Topics

Advertisement
UsernamePublicRestriction

Register

RS121796

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel